| Detected | Trial | Change |
|---|---|---|
| 2026-08-11 | NCT00935090 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer |
Enrollment closed, study ongoing |
| 2026-08-11 | NCT00935090 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer |
date change Primary completion moved earlier: 2027-05 -> 2024-04-04 |
| 2026-08-11 | NCT00935090 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer |
date change Completion moved earlier: 2028-05 -> 2027-04-04 |
| 2026-08-07 | NCT07343297 Ask Questions About Clinical Trials |
Recruitment opened |
| 2026-08-07 | NCT07343297 Ask Questions About Clinical Trials |
Trial sites expanded: 0 -> 8 locations |
| 2026-08-07 | NCT07343297 Ask Questions About Clinical Trials |
date change Primary completion pushed: 2026-12-30 -> 2027-12-30 |
| 2026-08-07 | NCT07343297 Ask Questions About Clinical Trials |
date change Completion pushed: 2027-04-05 -> 2028-04-05 |
| 2026-08-07 | NCT07042191 A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through… |
Enrollment closed, study ongoing |
| 2026-08-07 | NCT07042191 A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through… |
Enrollment increased: 20 -> 24 participants |
| 2026-08-07 | NCT07042191 A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through… |
date change Primary completion pushed: 2027-05 -> 2027-07 |
| 2026-08-07 | NCT07042191 A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through… |
date change Completion pushed: 2027-05 -> 2027-07 |
| 2026-07-30 | NCT02178163 Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV… |
Enrollment closed, study ongoing |
| 2026-07-30 | NCT02178163 Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV… |
Enrollment reduced: 1020 -> 619 participants |
| 2026-07-25 | NCT07098299 Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies |
Trial sites expanded: 1 -> 10 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-03 | NCT07743086 Impact of Duffy-null Associated Neutropenia on Chemotherapy Dosing | Phase 1/2 | Not Yet Recruiting |
| 2026-07-30 | NCT07735819 Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07130903 | Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With… | Metastatic Colorectal Adenocarcinoma | Recruiting |
| NCT06107738 | Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell… | Multiple Myeloma | Recruiting |
| NCT06420167 | DapagliFLOzin in Renal AL Amyloidosis (FLORAL) | Renal AL Amyloidosis | Recruiting |
| NCT06576115 | Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated… | Metastatic Pancreatic Adenocarcinoma | Recruiting |
| NCT04479267 | Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously… | Diffuse Large B-Cell Lymphoma | Active, Not Recruiting |
| NCT07735819 | Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed… | Low Grade Glioma | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT03147885 | Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell… | Diffuse Large B-Cell Lymphoma | Active, Not Recruiting |
| NCT07743086 | Impact of Duffy-null Associated Neutropenia on Chemotherapy Dosing | Solid Tumor Cancer | Not Yet Recruiting |
| Phase 1 | |||
| NCT05556473 | F-Tryptophan PET/CT in Human Cancers | Intracranial Glioma | Recruiting |
| NCT07098299 | Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies | Advanced Solid Tumor | Recruiting |
| Not specified | |||
| NCT06908629 | Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors | Cancer | Recruiting |
| NCT07095114 | A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer… | Ductal Carcinoma in Situ | Recruiting |
| NCT03750981 | C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience) | Cancer Survivors | Recruiting |
| NCT07118202 | TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma | Hepatocellular Carcinoma Recurrent | Recruiting |
| NCT07218432 | A Study of the TheraBionic P1 Device in Breast Cancer | Breast Cancer Stage I | Recruiting |
| NCT07436078 | Culturally Adapting an Intervention to Increase Genetic Testing in African American… | Female Breast Cancer | Recruiting |
| NCT05738005 | Dietary Reporting In The Amyloidoses | Amyloidosis | Recruiting |
| NCT07343297 | Ask Questions About Clinical Trials | Oncology | Recruiting |
| NCT07227831 | A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer | HER2-negative Breast Cancer | Not Yet Recruiting |
| NCT07672431 | Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast… | Triple Negative Breast Cancer | Not Yet Recruiting |
| NCT02178163 | Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV… | Recurrent Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT07042191 | A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through… | Healthy | Active, Not Recruiting |
| NCT00935090 | 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer | Brain and Central Nervous System Tumors | Active, Not Recruiting |